• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌少症老年患者队列 5 年死亡率的风险因素。

Risk factors for 5-year mortality in a cohort of elderly patients with sarcopenia.

机构信息

Department of Biology, College of Science, University of Bahrain, Sakhir Campus, Zallaq P.O. Box 32038, Kingdom of Bahrain.

Department of Biology, College of Science, University of Bahrain, Sakhir Campus, Zallaq P.O. Box 32038, Kingdom of Bahrain.

出版信息

Exp Gerontol. 2020 Jul 15;136:110944. doi: 10.1016/j.exger.2020.110944. Epub 2020 Apr 11.

DOI:10.1016/j.exger.2020.110944
PMID:32289488
Abstract

BACKGROUND

The association between multiple risk factors and the mortality of sarcopenic patients has not been studied. This study's aim is to report the prevalence of sarcopenia among a sample of Italian hospitalized older adults, describe the physical function, body fat composition, cognitive, inflammatory and nutritional status of sarcopenic compared with non-sarcopenic subjects, and determine the risk factors associated with mortality in sarcopenic patients.

METHOD

A total of 462 patients were enrolled and followed up for a period of 5 years. Sarcopenia was diagnosed according to the EWGSOP2 criteria. Factors associated with sarcopenia were identified with linear regression analysis. Logistic regression was applied to explore the association between the risk factors and mortality in sarcopenic subjects. Survival analyses and predictors of mortality were identified using Kaplan-Meier and Cox regression.

RESULTS

The prevalence of sarcopenia was 33.5%. Linear regression showed that sarcopenia was associated with Barthel index (B -9.63, p0.004), BMI (B -3.19, p<0.001) and android fat (B 1.85, p0.004). Of these factors, only the number of co-morbidities (OR 1.394 C95% 1.023-1.862 p 0.025) and MMSE scores (OR 0.857 C95% 0.79-0.930 p <0.001) were associated with mortality in sarcopenia. Kaplan-Meier and the log-rank tests showed the negative prognostic effect of low BMI (p0.007), albumin (p<0.001) and Barthel index (p 0.018). The Cox regression showed that mortality hazard is reduced with BMI >24.9 (HR 0.287 C95% 0.095-0.866 p 0.027).

CONCLUSION

Sarcopenia is associated with low physical function and BMI but higher android fat. Low Barthel, BMI and albumin can significantly decrease the survival rate in sarcopenic patients. Whereas BMI >24.9 is associated with lower mortality hazard.

摘要

背景

多种危险因素与肌少症患者的死亡率之间的关系尚未得到研究。本研究的目的是报告意大利住院老年患者样本中肌少症的患病率,描述与非肌少症患者相比,肌少症患者的身体功能、体脂肪组成、认知、炎症和营养状况,并确定与肌少症患者死亡率相关的危险因素。

方法

共纳入 462 例患者,并进行了 5 年的随访。根据 EWGSOP2 标准诊断肌少症。采用线性回归分析确定与肌少症相关的因素。应用逻辑回归探讨肌少症患者的危险因素与死亡率之间的关系。采用 Kaplan-Meier 和 Cox 回归分析确定生存分析和死亡率预测因素。

结果

肌少症的患病率为 33.5%。线性回归显示,肌少症与巴氏指数(B-9.63,p0.004)、BMI(B-3.19,p<0.001)和腹型脂肪(B 1.85,p0.004)有关。在这些因素中,只有合并症数量(OR 1.394 C95% 1.023-1.862 p 0.025)和 MMSE 评分(OR 0.857 C95% 0.79-0.930 p <0.001)与肌少症患者的死亡率相关。Kaplan-Meier 和对数秩检验显示低 BMI(p0.007)、白蛋白(p<0.001)和巴氏指数(p 0.018)对预后有负面影响。Cox 回归显示,BMI>24.9 时,死亡率危险度降低(HR 0.287 C95% 0.095-0.866 p 0.027)。

结论

肌少症与低身体功能和 BMI 有关,但与腹型脂肪较高有关。低巴氏、BMI 和白蛋白可显著降低肌少症患者的生存率。而 BMI>24.9 与较低的死亡率危险度相关。

相似文献

1
Risk factors for 5-year mortality in a cohort of elderly patients with sarcopenia.肌少症老年患者队列 5 年死亡率的风险因素。
Exp Gerontol. 2020 Jul 15;136:110944. doi: 10.1016/j.exger.2020.110944. Epub 2020 Apr 11.
2
[Related factors of sarcopenia in hospitalized elderly patients with coronary heart disease].[老年冠心病住院患者肌肉减少症的相关因素]
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Dec 24;47(12):979-984. doi: 10.3760/cma.j.issn.0253-3758.2019.12.007.
3
Comparing EWGSOP2 and FNIH Sarcopenia Definitions: Agreement and 3-Year Survival Prognostic Value in Older Hospitalized Adults: The GLISTEN Study.比较 EWGSOP2 和 FNIH 肌少症定义:老年住院患者中的一致性和 3 年生存预后价值:GLISTEN 研究。
J Gerontol A Biol Sci Med Sci. 2020 Jun 18;75(7):1331-1337. doi: 10.1093/gerona/glz249.
4
Understanding factors associated with sarcopenic obesity in older African women from a low-income setting: a cross-sectional analysis.了解低收入环境下老年非洲女性与肌肉减少性肥胖相关的因素:一项横断面分析。
BMC Geriatr. 2021 Apr 14;21(1):247. doi: 10.1186/s12877-021-02132-x.
5
Nutritional status and body fat mass: Determinants of sarcopenia in community-dwelling older adults.营养状况和体脂肪量:社区居住的老年人肌少症的决定因素。
Exp Gerontol. 2019 Jul 15;122:67-73. doi: 10.1016/j.exger.2019.04.009. Epub 2019 Apr 22.
6
Health-related quality of life and fall risk associated with age-related body composition changes; sarcopenia, obesity and sarcopenic obesity.与年龄相关的身体成分变化(肌肉减少症、肥胖症和肌少性肥胖症)相关的健康相关生活质量和跌倒风险。
Intern Med J. 2018 Aug;48(8):973-981. doi: 10.1111/imj.13935.
7
Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study.采用既定定义的德国肌少症肥胖症患病率:FORMOSA研究的基线数据。
Osteoporos Int. 2016 Jan;27(1):275-81. doi: 10.1007/s00198-015-3303-y. Epub 2015 Aug 29.
8
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors.类风湿关节炎中的肌肉减少症:患病率、疾病活动度的影响及相关因素
Rheumatol Int. 2017 Jun;37(6):1015-1020. doi: 10.1007/s00296-017-3665-x. Epub 2017 Mar 3.
9
Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria.根据 EWGSOP2 和 FNHI 标准定义的肌少症老年人中肥胖和糖尿病的患病率。
Aging Clin Exp Res. 2022 Jan;34(1):113-120. doi: 10.1007/s40520-021-01949-1. Epub 2021 Aug 16.
10
Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey.肌肉减少症、肌肉减少性肥胖与炎症:1999 - 2004年美国国家健康与营养检查调查结果
Clin Nutr. 2016 Dec;35(6):1472-1483. doi: 10.1016/j.clnu.2016.03.028. Epub 2016 Apr 7.

引用本文的文献

1
Associations between sarcopenia (defined by low muscle mass), inflammatory markers, and all-cause mortality in older adults: mediation analyses in a large U.S. NHANES community sample, 1999-2006.肌肉减少症(以低肌肉量定义)、炎症标志物与老年人全因死亡率之间的关联:对1999 - 2006年美国国家健康与营养检查调查(NHANES)大型社区样本的中介分析
Front Med (Lausanne). 2025 Jul 10;12:1515839. doi: 10.3389/fmed.2025.1515839. eCollection 2025.
2
The association of body composition and fat distribution with dysmobility syndrome in community-dwelling older adults: Bushehr Elderly Health (BEH) program.社区居住的老年人身体成分和脂肪分布与运动障碍综合征的关系:布什尔老年健康(BEH)计划。
BMC Musculoskelet Disord. 2023 Oct 12;24(1):809. doi: 10.1186/s12891-023-06934-5.
3
Old muscle, new tricks: a clinician perspective on sarcopenia and where to next.旧肌肉,新技巧:肌少症的临床观点及未来方向。
Curr Opin Neurol. 2023 Oct 1;36(5):441-449. doi: 10.1097/WCO.0000000000001185. Epub 2023 Jul 24.
4
Obesity as a premature aging phenotype - implications for sarcopenic obesity.肥胖作为一种早衰表型 - 对肌少症性肥胖的影响。
Geroscience. 2022 Jun;44(3):1393-1405. doi: 10.1007/s11357-022-00567-7. Epub 2022 Apr 26.
5
Sarcopenia and blood albumin: A systematic review with meta-analysis.肌肉减少症与血白蛋白:系统评价与荟萃分析。
Biomedica. 2021 Sep 22;41(3):590-603. doi: 10.7705/biomedica.5765.
6
Effect of Exercise Habit on Skeletal Muscle Mass Varies with Protein Intake in Elderly Patients with Type 2 Diabetes: A Retrospective Cohort Study.运动习惯对 2 型糖尿病老年患者骨骼肌量的影响因蛋白质摄入量而异:一项回顾性队列研究。
Nutrients. 2020 Oct 21;12(10):3220. doi: 10.3390/nu12103220.